(fidanacogene elaparvovec-dzkt)
BEQVEZ is supplied as a clear to slightly opalescent, colorless to slightly brown suspension for intravenous infusion with each mL containing 1 × 1013 vector genomes (vg).
Each vial of BEQVEZ contains 1 mL of extractable volume. The total number of vials will be customized to meet dosing requirements for individual patients based on their weight [see Dosage and Administration (2.1)]. Vial contents are to be diluted prior to infusion [see Dosage and Administration (2.2)].
{{section_name_patient}}
{{section_body_html_patient}}
Additional Resources
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine or vaccine.
Speak with a Pfizer Medical Information Professional regarding your Pfizer medicine or vaccine inquiry.
Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for a Pfizer medicine or a vaccine.
The submission will be reviewed during our standard business hours.
To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this medication, click the link below to submit your information:
Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website to report an adverse event related to a Pfizer medication, please call (800) 438-1985.
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or by calling (800) 332-1088.